Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-09-16

FDA Approved: IRBESARTAN — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)

View source ↗

Summary

FDA approved a supplemental application for IRBESARTAN from Unichem Pharmaceuticals (USA), Inc., updating the regulatory status of this generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Irbesartan (irbesartan)

Snippet

SUPPL AP for IRBESARTAN (IRBESARTAN)